LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.


ISPD International Conference on Prenatal Diagnosis and Therapy

, Singapore
Sunday, September 8, 2019 to Wednesday, September 11, 2019

Premier Supporter


Laboratory Corporation of America® Holdings Successfully Completes Acquisition of Sequenom, Inc.

Wednesday, September 7, 2016

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the successful completion of the offering period for the cash tender offer by its direct wholly owned subsidiary, Savoy Acquisition Corp. (Purchaser), for all outstanding shares of common stock of Sequenom, Inc. (NA

LabCorp Enhances VistaSeq Hereditary Cancer Test Portfolio with Addition of New Panels and New Genes That Can Be Assessed

Wednesday, May 3, 2017

LabCorp® (NYSE: LH) today announced a significant enhancement to its proprietary VistaSeqSM Hereditary Cancer portfolio, with ten new test panels focusing on the risk of specific hereditary cancer syndromes.

LabCorp Presents Nine Studies, Including Novel Research on Improving Genetic Counseling Quality, at the National Society of Genetic Counselors Annual Conference

Thursday, September 14, 2017

LabCorp (NYSE: LH), a leading global life sciences company, announced today that Integrated Genetics, a member of the LabCorp Specialty Testing Group, is presenting the results of nine studies relating to prenatal testing, including non-invasive prenatal testing (NIPT), and genetic counseling at

ACMG Annual Clinical Genetics Meeting

Seattle WA Tuesday, April 2, 2019 to Saturday, April 6, 2019